NYSE:DHR

Danaher Stock Forecast, Price & News

$247.41

+0.39 (+0.16 %)

(As of 06/14/2021 04:54 PM ET)

Add

Compare

Today's Range

$243.81

▼

$247.93

50-Day Range

$226.07

▼

$259.78

52-Week Range

$166.14

▼

$261.43

Volume1.88 million shs

Average Volume2.56 million shs

Market Capitalization$176.47 billion

P/E Ratio38.96

Dividend Yield0.34%

Beta0.69

30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Global Allergy Diagnostic and Treatment Market (2021 to 2029) - Featuring bioMerieux, Siemens Healthcare and Danaher Among Others - ResearchAndMarkets.com - Business Wire
June 14, 2021 | businesswire.com

With EPS Growth And More, Danaher (NYSE:DHR) Is Interesting
June 11, 2021 | finance.yahoo.com

Danaher Stock Shows Every Sign Of Being Modestly Overvalued - Yahoo Finance
June 11, 2021 | finance.yahoo.com

Danaher (DHR) is an Incredible Growth Stock: 3 Reasons Why - Nasdaq
June 9, 2021 | nasdaq.com

Danaher (DHR) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
June 9, 2021 | finance.yahoo.com

Danaher (DHR) is an Incredible Growth Stock: 3 Reasons Why
June 9, 2021 | finance.yahoo.com

Danaher (DHR) Shares Gain 11% in 3 Months: What's Driving It? - Yahoo Finance
June 9, 2021 | finance.yahoo.com

Danaher (DHR) Shares Gain 11% in 3 Months: What's Driving It? - Nasdaq
June 8, 2021 | nasdaq.com

Danaher (DHR) Shares Gain 11% in 3 Months: What's Driving It?
June 8, 2021 | finance.yahoo.com

Buy-the-Dip Candidates: Jim Cramer Would Rather Own DoorDash Than Uber
June 8, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
Current SymbolNYSE:DHR
Previous Symbol
CUSIP23585110
CIK313616
Webwww.danaher.com
Phone202-828-0850
Employees69,000
Year Founded1984

Sales & Book Value

Annual Sales$22.28 billion
Price / Sales7.92
Cash Flow$9.73 per share
Price / Cash Flow25.44
Book Value$51.39 per share
Price / Book4.81

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares713,279,000
Market Cap$176.47 billion
Next Earnings Date7/22/2021 (Estimated)
OptionableOptionable

Social Links

MarketRank^™

Overall MarketRank^™

1.90 out of 5 stars

Multi-Sector Conglomerates Sector

6th out of 49 stocks

Process Control Instruments Industry

4th out of 25 stocks

2.4 Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Buy. The company's average rating score is 2.86, and is based on 12 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $267.27, Danaher has a forecasted upside of 8.3% from its current price of $246.83.
Amount of Analyst Coverage
Danaher has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.1 Community Rank

Outperform Votes
Danaher has received 950 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Danaher has received 558 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Danaher has received 63.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote “Outperform” if you believe DHR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Danaher has a dividend yield of 0.34%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Danaher has only been increasing its dividend for 4 years.
Dividend Coverage
The dividend payout ratio of Danaher is 13.31%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 9.33% next year. This indicates that Danaher will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,051,818.00 in company stock.
Percentage Held by Insiders
Only 11.40% of the stock of Danaher is held by insiders.
Percentage Held by Institutions
77.57% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 0.78% in the coming year, from $8.93 to $9.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 38.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 20.05.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 38.87, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 25.63.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 4.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher or view top-rated stocks.

What stocks does MarketBeat like better than Danaher?

Wall Street analysts have given Danaher a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Danaher wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 22nd 2021.
View our earnings forecast for Danaher.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its earnings results on Wednesday, April, 21st. The conglomerate reported $2.52 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.67 by $0.85. The conglomerate earned $6.87 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 19.17% and a trailing twelve-month return on equity of 16.34%. Danaher's revenue was up 58.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.05 earnings per share.
View Danaher's earnings history.

How has Danaher's stock price been impacted by Coronavirus?

Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DHR stock has increased by 77.4% and is now trading at $247.19.
View which stocks have been most impacted by COVID-19.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Wednesday, May 5th. Stockholders of record on Friday, June 25th will be given a dividend of $0.21 per share on Friday, July 30th. This represents a $0.84 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend is Thursday, June 24th.
View Danaher's dividend history.

Is Danaher a good dividend stock?

Danaher pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.34%. Danaher has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Danaher is 13.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 9.33% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.

What guidance has Danaher issued on next quarter's earnings?

Danaher updated its first quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $6.82 billion-$6.82 billion, compared to the consensus revenue estimate of $6.13 billion.

What price target have analysts set for DHR?

14 equities research analysts have issued 1-year price objectives for Danaher's stock. Their forecasts range from $195.00 to $315.00. On average, they expect Danaher's share price to reach $267.27 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price.
View analysts' price targets for Danaher or view top-rated stocks among Wall Street analysts.

Who are Danaher's key executives?

Danaher's management team includes the following people:

Mr. Steven M. Rales, Co-Founder & Chairman (Age 70)
Mr. Rainer M. Blair, Pres, CEO & Director (Age 57, Pay $3.81M) (LinkedIn Profile)
Mr. Mitchell P. Rales, Co-Founder & Director (Age 64)
Mr. Matthew R. McGrew, CFO & Exec. VP (Age 49, Pay $2.46M) (LinkedIn Profile)
Mr. Brian W. Ellis, Sr. VP, Gen. Counsel & Chief Compliance Officer (Age 54, Pay $1.93M) (LinkedIn Profile)
Ms. Angela S. Lalor, Sr. VP of HR (Age 56, Pay $3.11M) (LinkedIn Profile)
Mr. Joakim Weidemanis, Exec. VP (Age 52, Pay $2.94M) (LinkedIn Profile)
Mr. Robert S. Lutz, Chief Accounting Officer & Sr. VP (Age 63)
Dr. Jose-Carlos Gutierrez-Ramos Ph.D., Sr. VP & Chief Science Officer (Age 57) (LinkedIn Profile)
Mr. Matthew E. Gugino C.F.A., CPA, CFA, CPA, VP of Investor Relations and FP&A

What is Rainer M. Blair's approval rating as Danaher's CEO?

27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Danaher's key competitors?

Some companies that are related to Danaher include Roper Technologies (ROP), AMETEK (AME), Keysight Technologies (KEYS), Fortive (FTV), Cognex (CGNX), MKS Instruments (MKSI), Sensata Technologies (ST), Senseonics (SENS), Mesa Laboratories (MLAB), Hurco Companies (HURC), ClearSign Technologies (CLIR), Crawford United (CRAWA), Hickok (HICKA), Sypris Solutions (SYPR) and International Isotopes (INIS).
View all of DHR's competitors.

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), The Home Depot (HD), The Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.36%), Price T Rowe Associates Inc. MD (4.51%), Massachusetts Financial Services Co. MA (2.08%), Morgan Stanley (1.92%), Geode Capital Management LLC (1.39%) and Edgewood Management LLC (1.16%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Ameriprise Financial Inc., Fred Alger Management LLC, JPMorgan Chase & Co., Nomura Asset Management Co. Ltd., BlackRock Inc., Royal Bank of Canada, and CIBC Private Wealth Group LLC. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr, and William King.
View insider buying and selling activity for Danaher or view top insider-selling stocks.

Which institutional investors are buying Danaher stock?

DHR stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Amundi Asset Management US Inc., Capital International Investors, Price T Rowe Associates Inc. MD, Oak Ridge Investments LLC, Janus Henderson Group PLC, Bank of New York Mellon Corp, and Axiom Investment Management LLC.
View insider buying and selling activity for Danaher or or view top insider-buying stocks.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $247.19.

How much money does Danaher make?

Danaher has a market capitalization of $176.32 billion and generates $22.28 billion in revenue each year. The conglomerate earns $3.65 billion in net income (profit) each year or $6.31 on an earnings per share basis.

How many employees does Danaher have?

Danaher employs 69,000 workers across the globe.

Does Danaher have any subsidiaries?

The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima KK, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Finance ApS, Beckman Holdings Ltd., BioTector Analytical Systems Ltd, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., ChemTreat International Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology (Guangzhou) Co. Ltd., Cytiva Biotechnology (Hang Zhou) Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, Cytiva Sweden Holding AB, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Japan Finance Sarl, DH Life Sciences LLC, DH Netherlands BV, DH Technologies Development Pte Ltd., DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher (Shanghai) Management Co. Ltd., Danaher Hong Kong Limited, Danaher Medical ApS, Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Finance BV, Esko Graphics BV, Esko Software BV, FHAB Company AB, Fluke, G. Lufft Mess- und Regeltechnik GmbH, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions New Zealand, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies (Shanghai) Co Ltd., Global Life Sciences Technologies Japan KK, Hach Company, Hach Lange Finance GmbH, Hach Lange GmbH, Hach Lange Sàrl, Hach Sales & Services Canada LP, Hach Ultra Japan KK, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Iris International Inc., Joslyn Holding Company LLC, KVHG GmbH, KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS*, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Microtest, Molecular Devices, Molecular Devices (Austria) GmbH, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nihon Pall Manufacturing Limited, Nobel Biocare, OTT Hydromet Corp, Pall, Pall (Canada) ULC, Pall (China) Co. Ltd., Pall (Schweiz) GmbH, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., QHC Ireland Finance Limited, Radiometer, Radiometer Basel AG, Radiometer K.K., Radiometer Medical ApS, Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, SH Switzerland Finance Sarl, Sea-Bird Electronics Inc., SenDx Medical Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Sutron, Sybron Dental Specialties, TCIL Ireland Finance Ltd., Tektronix, Thomson Industries, Tianjin Bonna-Agela Technologies Co. Ltd., Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (Shanghai) Co. Ltd., Videojet Technologies Europe B.V., Videojet Technologies Inc., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, X-Rite Switzerland GmbH, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..

When was Danaher founded?

Danaher was founded in 1984.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

Where are Danaher's headquarters?

Danaher is headquartered at 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 6/14/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here